InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Explore the full record of transactions filed by Weber Kathleen Gallagher, Chairman & CEO. Director active across 2 companies, notably Orasure Technologies INC. Cumulatively, 4 disclosures have been recorded. The latest transaction was filed on 1 February 2022 — Retenue fiscale. Regulator: SEC (Form 4). All data is accessible without signup.
Declarations4 total
€11,5741,467 shares@ €7.88980.0056% mcap2.5% of flow
Common Stock
SEC:0001593968-22-000406·
€11,5741,467 shares@ €7.88980.0056% mcap2.5% of flow
Common Stock
SEC:0001593968-22-000406:0·
€443,11860,901 shares@ €7.2760.21% mcap97.5% of flow
Common Stock
SEC:0001593968-22-000180·
€443,11860,901 shares@ €7.2760.21% mcap97.5% of flow
Common Stock
SEC:0001593968-22-000180:0·
4 of 4 declarations
About Weber Kathleen Gallagher
Kathleen Gallagher Weber is the President of Molecular Solutions at ORASURE TECHNOLOGIES INC. She leads the company's strategic initiatives and oversees its operations. Her expertise in the healthcare sector is essential for developing innovative solutions.
